| Ryan Johnson, | |
|
6610 S Scatterfield Rd, Anderson, IN 46013-9605 | |
| (765) 683-5210 | |
| (765) 683-5265 |
| Full Name | Ryan Johnson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 6610 S Scatterfield Rd, Anderson, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841600582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | 051297037 (Illinois) | Secondary |
| 1835P1200X | Pharmacist - Pharmacotherapy | 26025309A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Johnson, 6610 S Scatterfield Rd, Anderson, IN 46013-9605 Ph: (765) 683-5210 | Ryan Johnson, 6610 S Scatterfield Rd, Anderson, IN 46013-9605 Ph: (765) 683-5210 |
News Archive
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease.
A collaboration between the Universities of Bristol, Cardiff and Swansea has been awarded £5 million by the UK Clinical Research Collaboration (UKCRC) to establish a Centre of Excellence for research into public health.
Scientists at the Virginia Tech Carilion Research Institute have found evidence that may disrupt conventional understanding about how electrical activity travels in the heart -; a discovery that potentially can lead to new insight into medical problems such as heart arrhythmia and sudden cardiac death.
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
› Verified 3 days ago
Lynette Sullivan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Broadway St, Anderson, IN 46012 Phone: 765-643-1515 | |
Mr. Willard Grubb, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6610 S Scatterfield Rd, Anderson, IN 46013 Phone: 765-683-5233 Fax: 765-683-5265 | |
Timothy Cosman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Broadway St, Anderson, IN 46012 Phone: 765-643-1515 | |
Vadim Shinkevich, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3824 Main St, Anderson, IN 46013 Phone: 860-989-7520 | |
Reham Nakhla, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-5025 | |
Mr. James C Hoffman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 505 Madison Ave, Anderson, IN 46016 Phone: 765-643-3716 Fax: 765-643-0265 | |
Dr. Francis Oppong-asante, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-5365 Fax: 765-683-9105 |